Economic evaluation of the PAX-D study
Dates: 2019-2024
Funding: UK NIHR EME
Collaborator(s): Department of Psychiatry, University of Oxford
Web: https://paxd.web.ox.ac.uk/
Information: Judit Simon (co-PI), Timea Helter, Agata Laszewska
The PAX-D study is a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. The DHE leads the main health economic analysis.
Result(s):
- Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, et al. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evid Based Ment Health. 2022 Apr;25:77-83. DOI:10.1136/ebmental-2021-300282